Cancer

Cancer costs wallop employers

Cancer is the main source of catastrophically high medical claims for companies and their employees, according to new data from stop-loss insurer Sun Life.

Why it matters: Self-funded employers, or those that directly pay for their workers’ medical claims, usually buy "stop-loss" coverage to insure themselves from unpredictably costly diagnoses. And cancer has been the highest-cost condition for stop-loss claims every year since 2013.

Big Pharma wants to sell cancer drugs

Pfizer sign
Photo: Spencer Platt/Getty Images

Pfizer's $11.4 billion takeover of Array BioPharma highlights how eager industry titans are to commercialize cancer medications, making cancer the most in-demand pharmaceutical asset outside of gene therapy.

The state of play: Big Pharma wants to expand cancer lineups because cancer drugs command huge price tags that health insurers and society usually pay for uncritically.